HLB Life Science Co., Ltd. (KOSDAQ: 067630)

HLB Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48,103	16,769	30,978	31,254	37,157	36,769
Short-Term Investments	13,576	11,298	12,350	24,690	17,858	31,479
Trading Asset Securities	10,243	50,793	88,661	84,017	103,019	107,508
Cash & Short-Term Investments	71,921	78,860	131,989	139,961	158,034	175,756
Cash Growth	65.65%	-40.25%	-5.70%	-11.44%	-10.08%	-9.77%
Accounts Receivable	12,546	11,464	13,072	11,648	17,599	38,139
Other Receivables	4,431	2,371	2,116	1,123	369.92	1,916
Receivables	16,987	14,646	16,202	14,157	19,349	40,155
Inventory	5,461	5,267	10,867	1,769	2,082	7,149
Prepaid Expenses	-	448.74	208.4	281.34	395.85	114.66
Other Current Assets	1,204	238.85	1,509	654.91	1,468	491.76
Total Current Assets	95,574	99,460	160,776	156,822	181,329	223,667
Property, Plant & Equipment	83,523	72,918	92,089	22,081	22,935	23,056
Long-Term Investments	213,078	146,038	44,749	24,346	38,850	54,717
Goodwill	-	1,772	21,925	-	1,896	22,603
Other Intangible Assets	52,269	54,029	69,506	62,809	75,440	73,749
Long-Term Accounts Receivable	-	-	341.17	363.96	571.04	777.4
Other Long-Term Assets	49,096	49,158	22,264	4,262	6,060	6,252
Total Assets	493,651	423,500	411,790	270,800	327,197	404,935
Accounts Payable	6,216	5,160	9,384	10,278	5,548	26,726
Accrued Expenses	-	2,240	697.15	717.82	584.35	465.2
Short-Term Debt	43,485	106,761	7,920	-	-	700
Current Portion of Long-Term Debt	13,420	7,060	387.2	-	-	-
Current Portion of Leases	584.46	922.33	2,145	668	377.78	698.94
Current Income Taxes Payable	-	7,555	132.13	-	19.36	597.68
Current Unearned Revenue	-	31.49	38.42	24.01	631.24	146.5
Other Current Liabilities	4,174	5,727	6,081	1,848	10,705	10,510
Total Current Liabilities	67,880	135,457	26,785	13,536	17,865	39,845
Long-Term Debt	61,832	51,410	136,189	3,500	10,734	10,336
Long-Term Leases	232.62	424.01	832.41	452.62	279.57	238.91
Long-Term Deferred Tax Liabilities	2,962	3,345	10,033	5,758	9,667	10,225
Other Long-Term Liabilities	1,041	1,036	1,201	224.73	250.38	9,125
Total Liabilities	134,279	192,288	175,724	24,188	39,453	70,510
Common Stock	59,807	51,407	48,831	48,223	24,009	24,002
Additional Paid-In Capital	286,440	168,141	222,910	240,895	294,133	294,044
Retained Earnings	11,084	10,431	-40,963	-46,832	-60,188	-4,250
Treasury Stock	-679.97	-679.97	-	-	-	-
Comprensive Income & Other	2,277	1,499	3,947	3,904	29,227	20,027
Total Common Equity	358,928	230,797	234,725	246,189	287,181	333,823
Minority Interest	445.04	416.21	1,342	422.87	563.11	602.14
Shareholders' Equity	359,373	231,213	236,067	246,612	287,744	334,425
Total Liabilities & Equity	493,651	423,500	411,790	270,800	327,197	404,935
Total Debt	119,555	166,578	147,473	4,621	11,391	11,974
Net Cash (Debt)	-47,634	-87,718	-15,484	135,340	146,642	163,782
Net Cash Growth	-	-	-	-7.71%	-10.46%	62.01%
Net Cash Per Share	-451.23	-861.84	-153.36	1362.33	1481.19	1759.97
Filing Date Shares Outstanding	118.6	101.8	96.71	100.44	49.5	98.98
Total Common Shares Outstanding	118.6	101.8	101.71	100.44	99.01	98.98
Working Capital	27,694	-35,997	133,991	143,286	163,464	183,822
Book Value Per Share	3026.46	2267.23	2307.67	2451.22	2900.59	3372.61
Tangible Book Value	306,659	174,996	143,294	183,380	209,845	237,470
Tangible Book Value Per Share	2585.73	1719.07	1408.78	1825.85	2119.48	2399.16
Land	-	21,471	29,580	9,065	9,622	10,296
Buildings	-	23,221	19,950	4,547	5,511	1,329
Machinery	-	39,219	30,949	12,906	12,541	13,269
Construction In Progress	-	8,472	18,390	1,324	392.54	3,786

Source: S&P Capital IQ. Standard template. Financial Sources.